ライフサイエンスコーパス: subgroup

1 mpare rates of NCD occurrence by demographic subgroup.

2 not associated with improved outcomes in any subgroup.

3 this young cohort, particularly in the older subgroup.

4 oreensis subgroup and two in the P. jessenii subgroup.

5 eased (p < 0.05) in a TLR5(392Stop) SNP rUTI subgroup.

6 ies seem to perform well in this challenging subgroup.

7 (78% at 6 months) in the screening high-risk subgroup.

8 , among which 19 of them belong to TRIM C-IV subgroup.

9 in which all, except one, formed a distinct subgroup.

10 hesis of all members in the homohalichondrin subgroup.

11 will offer new therapeutic avenues for this subgroup.

12 DM was a prespecified subgroup.

13 p=0.011) subgroups compared with the LOH low subgroup.

14 mtansine (T-DM1) with or without ET for this subgroup.

15 tal (FFT: 44% vs LFT: 35%, P = 0.330) cancer subgroups.

16 for patients in several recognized high-risk subgroups.

17 ell types and that each tissue contained two subgroups.

18 e a role for losartan in specific vulnerable subgroups.

19 ty and rehospitalization was similar for all subgroups.

20 lower fish consumption than the other Asian subgroups.

21 minants of postresection survival in certain subgroups.

22 evolution pattern, allowed identification of subgroups.

23 ity in multivariate analyses in a variety of subgroups.

24 tional scores in the benign versus malignant subgroups.

25 copic and open groups) and also on the study subgroups.

26 proximately 10% of the heritability in the 2 subgroups.

27 k of colorectal cancer in most racial/ethnic subgroups.

28 iations in biomarker levels across the Asian subgroups.

29 , and behavioral covariates across the Asian subgroups.

30 ients into appropriate prognostic/predictive subgroups.

31 ional differences among the pacemaker neuron subgroups.

32 nd epithelial cell function for these asthma subgroups.

33 were conducted after exclusion of these two subgroups.

34 nome sequences of members of their neighbour subgroups.

35 de methylation variability identified cDLBCL subgroups.

36 asopressin and Septic Shock Trial in lactate subgroups.

37 bgroups and that H3N2 titers fall into three subgroups.

38 weight gain into DIO-prone and DIO-resistant subgroups.

39 ed and examined across multiple prespecified subgroups.

40 Patterns were consistent across clinical subgroups.

41 e consistent across the prespecified patient subgroups.

42 risk (MBGrp3-LR [n=50] and MBGrp4-LR [n=73]) subgroups.

43 nplanned readmission rate was evident in all subgroups.

44 neither overall or in any of the 26 examined subgroups.

45 ment in diet quality in all sociodemographic subgroups.

46 Adverse events were similar between the subgroups.

47 in the risk of advanced AMD in some genotype subgroups.

48 othesis of the PREDICT study via analyses of subgroups.

49 variants have different effect sizes in two subgroups.

50 Of those 60 in the photographic subgroup, 10 were rated using not only the SCAR scale bu

51 g(-1), P < 0.05 vs. controls) and high-dose subgroups (37.2 +/- 7.8 nmol x min(-1) x g(-1), P < 0.01

52 the placebo group at 6 and 9 months in both subgroups, 5 to 7 and >7 mm of initial PD.

53 (including the normal tension glaucoma (NTG) subgroup), 8 with PACG and 2 with XFS.

54 Functional stroke mimics are an important subgroup admitted to acute stroke services and have a di

55 Differentiated analysis of MR imaging subgroups again revealed no significant changes in gamma

56 t survival models, incorporating these novel subgroups along with secondary clinicopathological and m

57 op a risk score model to stratify prognostic subgroups among 106 patients developing posttransplant r

58 for cT3N0M0 esophageal cancer patients, with subgroup analyses by histological type (squamous cell ca

59 Sensitivity and subgroup analyses by insurance type, pharmacy type, sex,

60 re compared, as well as discharge home, with subgroup analyses by surgical risk, demographics, and co

61 Subgroup analyses examined differences in kappa statisti

62 Predefined subgroup analyses found no interaction with ejection fra

63 However, subgroup analyses indicated that participants who consum

64 Subgroup analyses of adults vs children did not reveal d

65 ary end points included overall survival and subgroup analyses of event-free survival according to di

66 not meet its primary endpoints, prespecified subgroup analyses of patients with EGFR FISH-positive sq

67 Subgroup analyses on patients with increased lipopolysac

68 Subgroup analyses revealed stronger positive association

69 Subgroup analyses showed no benefit from EGDT for patien

70 Subgroup analyses showed no significant interaction betw

71 Subgroup analyses showed that diets providing the larges

72 Specifically, subgroup analyses showed that greater use of positive re

73 Subgroup analyses showed that late-onset depression was

74 Meta-regression and subgroup analyses were performed to evaluate whether pub

75 Subgroup analyses were performed to investigate the effe

76 In the subgroup analyses, clofarabine improved overall survival

77 In subgroup analyses, induction therapy may be associated w

78 Although differences existed in prespecified subgroup analyses, intubation was not associated with im

79 stigational agent was well tolerated and, in subgroup analyses, participants who demonstrated partial

80 with novel oral anticoagulants were seen in subgroup analyses, with no significant difference accord

81 disorder associations will be missed without subgroup analyses.

82 missions was heterogeneous across population subgroups, analyses included interactions of ECT with ag

83 ol to intervention groups and do not include subgroup analysis for unstable angina.

84 Predefined subgroup analysis in early presenters (</=2 hours) revea

85 dent CVD and death, including a prespecified subgroup analysis in participants with vitamin D deficie

86 Subgroup analysis of 127 patients meeting only the old d

87 Prespecified subgroup analysis of a randomized clinical trial of endo

88 Subgroup analysis of death and CVE rates was performed f

89 nts are underrepresented in clinical trials, subgroup analysis of large clinical trials suggests they

90 A subgroup analysis of neoadjuvant therapies showed a supe

91 al atherosclerotic stenosis interaction in a subgroup analysis of patients in the Acute Stroke or Tra

92 ter aortic valve replacement, we conducted a subgroup analysis of patients undergoing only coronary a

93 We conducted a post hoc subgroup analysis of patients with honeycombing on HRCT

94 In subgroup analysis of trial participants age 9-16 years,

95 Subgroup analysis on HD patients who experienced an infe

96 Subgroup analysis revealed that female gender, aspirin i

97 Subgroup analysis was performed by external cause of TBI

98 luded participants with physical illness for subgroup analysis, and excluded participants with comorb

99 In a planned subgroup analysis, the transfusion rate was 4.6% in wome

100 ed from the United States for a prespecified subgroup analysis.

101 in comparison to standard variant-by-variant subgroup analysis.

102 of the receptor-binding site common to this subgroup and a unique insertion in the 260-loop compared

103 Risk of bias was a significant moderator in subgroup and meta-regression analyses (slope beta = -0.1

104 Subgroup and meta-regression analyses revealed that medi

105 efaciens LoaP as a paradigm for this protein subgroup and showed that it regulated the transcriptiona

106 ost (37) were classified in the P. koreensis subgroup and two in the P. jessenii subgroup.

107 Performance was evaluated in subgroups and across a range of troponin concentrations

108 orts to identify consensus primary molecular subgroups and characterise their clinical and biological

109 ometry revealed that nearly all pathological subgroups and even individual patients share atrophy in

110 fication in 10 exclusive primary cytogenetic subgroups and in secondary subgroups, including complex

111 d results, with positive association in some subgroups and non-significant or negative association in

112 09 H1N1 antibody titers fall into four titer subgroups and that H3N2 titers fall into three subgroups

113 e IV populations may harbour stress-tolerant subgroups, and thus fitness tradeoffs may govern Cu-tole

114 significant or negative association in other subgroups; and eight articles found no association betwe

115 s targeting Notch1 in a genotype-defined ACC subgroup are warranted.

116 ve methods for identifying these ICU patient subgroups are lacking.

117 on in all patients and in the adenocarcinoma subgroup as well as the TP53/EGFR comutation in adenocar

118 but similar for all arms across cytogenetic subgroups, as was remission duration and overall surviva

119 lin and eosin stain aspect defined a new HCA subgroup at a high risk of bleeding.

120 Patient subgroups based on DEGs were created by hierarchical clu

121 1 (central review), assessed in prespecified subgroups based on PD-L1 expression and in all patients.

122 lex clinical phenotype into more homogeneous subgroups based on the endophenotype [panel of biomarker

123 Cluster analysis suggested the following 2 subgroups based on the number of family members with a n

124 Validation group patients divided into 10 subgroups by the original and new treatment-integrated B

125 eater with empagliflozin than placebo in all subgroups by UACR status.

126 Within subgroups categorized by both SBP (120-139 mm Hg, 140-15

127 These studies have revealed biologic subgroups characterized by distinct molecular, pathologi

128 and other Hispanic), and across three Asian subgroups (Chinese, Asian Indian, and other Asian).

129 ith CP in both initial PD = 5 to 7 and >7 mm subgroups compared with placebo.

130 001) and LOH high (0.62, 0.42-0.90, p=0.011) subgroups compared with the LOH low subgroup.

131 s attended all three assessments and in this subgroup, complete clinical response was reported in 441

132 MBSHH was split into age-dependent subgroups corresponding to infant (<4.3 years; MBSHH-Inf

133 We then subdivided AAC eyes into four subgroups: crowded-angle (CR), lens subluxation (LS) pup

134 Ns) called D MNs, which are divided into two subgroups: DD and VD.

135 treatment, and control in 264 475 population subgroups-defined a priori by all possible combinations

136 Cross-validated subgroup-dependent survival models, incorporating these

137 The study was inadequately powered to detect subgroup effects.

138 Follow-up analyses revealed significant subgrouping effects on the left (d1.48) and right NAc (d

139 The result was consistent among analyzed subgroups (eg, male v female, age-adjusted International

140 Two subgroups emerged.

141 al stays to retrospectively identify patient subgroups from a large, heterogeneous ICU population.

142 nging to Group 3 and Group 4 medulloblastoma subgroups, greatly enhancing previous knowledge.

143 assessed with 8th edition criteria, no stage subgroup had a majority of patients, and the CPE was 0.5

144 .001), those in the middle predicted benefit subgroup had a NNT of 76 (ARR = 0.013, 95% CI: -0.0001,

145 articipants in the highest predicted benefit subgroup had a number needed to treat (NNT) of 24 to pre

146 , 0.026; P = 0.053), and those in the lowest subgroup had no significant risk reduction (ARR = 0.006,

147 al cancer surgery (N=2328), all laparoscopic subgroups had significantly higher total hospital costs,

148 Multiple cytogenetic subgroups have been described in adult Philadelphia chro

149 rst SARE was longer across symptom frequency subgroups (hazard ratios 0.54 [95% CI 0.34-0.86] for 0-1

150 function, and asthma symptom control across subgroups identified by baseline asthma symptom frequenc

151 PD, CAL, and DDR% were evaluated in two subgroups in both the placebo and MF group: 1) initial P

152 entified two sepsis response signature (SRS) subgroups in fecal peritonitis associated with early mor

153 was no significant heterogeneity between the subgroups in relation to Western dietary pattern scores.

154 [BP] treatment among the 6 key, prespecified subgroups in SPRINT: age >/=75 years, prior cardiovascul

155 ociation with clinical outcomes in different subgroups in the ICU.

156 There was broad consistency across most subgroups in the sensitivity analyses and whether 1- or

157 time were found among the 3 largest Hispanic subgroups in the United States.

158 However, for the subgroups in which the imaging modality showed a suggest

159 oth high-risk and standard-risk cytogenetics subgroups: in high-risk patients, the hazard ratio (HR)

160 Exploratory subgroups included massively transfused and severe TBI p

161 Histological subgroups included: early lesions (n = 1); polymorphic P

162 for guiding antihypertensive treatment among subgroups including older adults, young adults, and thos

163 Results were consistent across most subgroups, including among intermediate- and high-risk p

164 imary cytogenetic subgroups and in secondary subgroups, including complex and monosomal karyotypes.

165 ffer systematically between the phylogenetic subgroups, indicating high potential for chemotaxonomic

166 There was no significant treatment-by-subgroup interaction (P = 0.8139).

167 There were 2 significant treatment-by-subgroup interactions: patients without elevated jugular

168 s that localization of the APC-dependent RNA subgroup is functionally important for cell migration.Ad

169 either the SrcA (Yes, Src, Fyn, Fgr) or SrcB subgroup (Lck, Lyn, Blk, Hck).

170 from following an ATS at the population and subgroup levels and how to evaluate its robustness to mo

171 group, and serial sampling demonstrated that subgroup membership is dynamic during intensive care uni

172 incompletely described, and which population subgroups might benefit from cancer screening is unknown

173 Subgroup multivariable analysis showed stronger mortalit

174 ished in 2011/2012 (T0), with follow-up of a subgroup (n = 3,992 invited) in 2013 (T1; n = 2,228) and

175 n LVEF in FM versus NFM were observed in the subgroup (n=130) with viral myocarditis.

176 Two methods discriminated phenotypic subgroups, namely, a sum across 7 traits and a regressio

177 nontrivial clustering problem, with neither subgroups nor subgroup-specific networks known at the ou

178 This analysis looks at the subgroup of 157 men with minimal comorbidities or no com

179 was 89% (95% CI, 75%-97%; kappa = 0.88) in a subgroup of 37 participants with photographs considered

180 A subgroup of 493 men met criteria for AAMI based on basel

181 In the subgroup of 691 patients, 5 year overall survival in pat

182 post hoc analysis, stent length was the only subgroup of 7 that had an effect on outcome.

183 atio=1.86 [1.55-2.54]; P<0.001), even in the subgroup of asymptomatic even in the subgroup of asympto

184 in the subgroup of asymptomatic even in the subgroup of asymptomatic patients (adjusted hazard ratio

185 cancer is viewed clinically as an aggressive subgroup of breast cancer.

186 receptor potential vanilloid 4 (TRPV4) in a subgroup of breast cancers of the basal molecular subtyp

187 by faltering limited to a growth-restricted subgroup of children.

188 f CML-SCs, including the identification of a subgroup of CML-SCs with a distinct molecular signature

189 ite outcome was compared by treatment in the subgroup of eyes that did not have vision-impairing cent

190 Surgical data were analyzed in a subgroup of eyes with microcystoid macular changes treat

191 eatment strategies targeting IL-17A for this subgroup of fungus-exposed patients with difficult-to-tr

192 ated in Alb-R26(Met) tumors, characterizes a subgroup of HCC patients with poor prognosis.

193 sarcomere mutations represent a nonfamilial subgroup of HCM.

194 Similar findings were observed in a subgroup of high immune risk patients.

195 ymphoblastic leukemia (T-ALL), a heterogenic subgroup of human leukemia characterized by a high incid

196 s investigation was a post hoc analysis of a subgroup of laser control eyes in 2 phase 3 trials-VISTA

197 Visual and anatomic outcomes in a subgroup of laser control eyes receiving treatment with

198 A large subgroup of naphthoquinone-based meroterpenoids exhibits

199 tic leukaemia (HD-ALL) being the most common subgroup of paediatric ALL, its aetiology remains unknow

200 improvement at 1 and 2 years in the smaller subgroup of participants with PDR at baseline.

201 o determine the outcomes in the prespecified subgroup of patients >/=75 years old (n=2010; 18%).

202 tricle outflow tract represent a significant subgroup of patients referred for catheter ablation.

203 ysed both the overall trial population and a subgroup of patients who had attended each of the three

204 In the subgroup of patients who lost weight, glycemia, homeosta

205 emic events and bleeding was analyzed in the subgroup of patients with a history of cerebrovascular e

206 In the subgroup of patients with baseline urinary albumin-to-cr

207 ly treated for depression constitute a large subgroup of patients with breast cancer who are at risk

208 was 3.1 (CI, 1.7 to 5.8) in the prespecified subgroup of patients with ECD versus 1.3 (CI, 0.9 to 1.9

209 th autism spectrum disorders (ASDs) within a subgroup of patients with elevated blood 5-HT levels, li

210 ivity and tolerability of savolitinib in the subgroup of patients with MET-driven PRCC.

211 Higher levels of cfDNA were detected in the subgroup of patients with metabolically active bone lesi

212 A subgroup of patients with noninfected neutrophilic RA wa

213 A subgroup of patients with TH2/TH17-low asthma had neutro

214 In a subgroup of patients with type 2 diabetes, a decrease in

215 In a subgroup of patients, BRCA1/2 protein expression was tes

216 In a subgroup of patients, the in vivo stability of (68)Ga-NO

217 de dysfunctions at the nodes of Ranvier in a subgroup of patients.

218 The subgroup of PLS-type PPR proteins were found to be the m

219 In a subgroup of rugby athletes (n = 77), we assessed muscle

220 However, in the subgroup of small diameter stents (</=3 mm; n = 95), spe

221 The subgroup of studies with a mean BMI >/=30 exhibited subs

222 Tspan5 is a member of a subgroup of tetraspanins referred to as TspanC8.

223 mes acting on bulky substrates as a distinct subgroup of the BVMO class.

224 f the inverted repeat structure (IR/DR) in a subgroup of the Tc1/mariner superfamily of transposons h

225 A subgroup of these patients also has coronary microvascul

226 VNS paired with tones may be effective for a subgroup of tinnitus patients and provides impetus for a

227 n, our gene expression analyses identified a subgroup of tumours associated with hypoxia and HIF sign

228 ateral CA1 subfield volumes was found in the subgroup of UHR subjects whose subthreshold symptoms per

229 iods after each shooting, overall and within subgroups of acquirers.

230 erlying mechanisms and ways to best identify subgroups of AD patients at risk for ADHD are poorly und

231 While more vulnerable subgroups of children may exist, the low overall differe

232 risk allele in the MET promoter, enriched in subgroups of children with autism spectrum disorder, red

233 The monophyly of the major subgroups of Copepoda, including Progymnoplea Lang, 1948

234 n patients with unprovoked VTE, including in subgroups of different ages or those that have had diffe

235 r determining whether phenotypically defined subgroups of disease cases represent different genetic a

236 tant differences between empirically derived subgroups of ICU patients that are not typically reveale

237 dy-based meta-analysis was restricted to the subgroups of patients on aspirin therapy (n=21 722) from

238 assess prevalence of depressive symptoms in subgroups of patients referred to a tertiary Lyme center

239 needed that target therapies toward specific subgroups of patients with ARDS on the basis of both sev

240 Using CART analysis, we stratified 2 subgroups of patients with high (65%) and low (26%-29%)

241 f MAG vs LITA+SVG among overall and selected subgroups of patients.

242 We have identified two subgroups of patients; firstly, MP with stable and chara

243 ies are needed to determine whether specific subgroups of pediatric patients undergoing cardiopulmona

244 om those in the comparison groups and detect subgroups of persons with ME/CFS who may have different

245 ed the endogenous neurodynamics of hand M1's subgroups of pyramidal neuronal pools in each of our sub

246 covered classes of riboswitches might reveal subgroups of RNAs that respond to different effectors.

247 erall, no single equation worked well across subgroups of sex and race/ethnicity.

248 atient recruitment of relatively homogeneous subgroups of subjects for clinical trials.

249 er of people in control is ubiquitous in all subgroups of the Chinese population and warrants broad-b

250 alidation Study (2010-2012), conducted among subgroups of the Nurses' Health Studies.

251 These results were consistent when subgroups of the severe bacterial infection composite we

252 an evolutionary model in which contemporary subgroups of the superfamily have diverged in a radial m

253 rds regression to assess PrEP efficacy among subgroups of women defined by bacterial vaginosis status

254 ort studies provide an opportunity to define subgroups on the basis of disease trajectories, which ma

255 ons (20% increase in sensitivity) in patient subgroups or even individual patients.

256 Results In the LPS subgroup, OS was significantly improved: 15.6 versus 8.4

257 Patients in the apolipoprotein E (ApoE)e3/e3 subgroup over time exhibited an increase of protein kina

258 were greater in three prespecified high-risk subgroups: patients with diabetes, those 70 years of age

259 ven parsing of neural connectivity to reveal subgroups present across depressed and healthy individua

260 ned in various subpopulations, including the subgroup receiving anticoagulant therapy.

261 Disparities among subgroups related to the incidence and mortality of thes

262 A patient subgroup remained on blinded treatment for up to 52 week

263 Fructose substitution in some subgroups resulted in significantly but only slightly lo

264 ar of life and allergic outcomes vary within subgroups selected a priori (race, gender and delivery m

265 per year, whereas patients in the ApoEe3/e4 subgroup showed individually divergent results with an M

266 ustering problem, with neither subgroups nor subgroup-specific networks known at the outset.

267 n of the pandemic multidrug-resistant clonal subgroup ST131-H30.

268 PRSs with characteristics and GPRSs with MDD subgroups stratified according to the most relevant char

269 Racial disparities also persisted in subgroups stratified by age (>/=60 and <60 years of age)

270 tently observed across multiple outcomes and subgroups support the consideration of MAG for a broader

271 nhibitors, and depletion of PKCdelta in this subgroup suppresses apoptosis through increased activati

272 In a subgroup, sympathetic/parasympathetic modulation was ass

273 state cancer to identify clinically distinct subgroups that benefit from specific therapies.

274 and further divided into distinct molecular subgroups that reflect differences in the age of onset,

275 h species come from a single actinopterygian subgroup, the acanthomorph or spiny-rayed fishes.

276 lear phylogenetic signal from one ochrophyte subgroup, the lineage containing pelagophytes and dictyo

277 h their phylogenetic distance from described subgroups, the genome sequences of strains in these subc

278 target mismatch criteria were analyzed as a subgroup to identify whether they had different treatmen

279 ryoglobulinemia is categorized into two main subgroups: type I, which is seen exclusively in clonal h

280 Fish consumption across the Asian subgroups varied, with Asian Indians having lower fish c

281 p 1 vs 2 was +11.6 vs +8.5 (P = .32) and for subgroups was +10.6 vs +7.8 (P = .23) for PCSME and +13.

282 centrations, differences between demographic subgroups were comparable in the 2 surveys.The results i

283 either primary surgery or primary radiation subgroups were examined (log-rank P < .001 for all).

284 Comparisons of risk for death between subgroups were made with the log-hazard ratio of the Cox

285 ely to participate; therefore, these patient subgroups were underrepresented in the study findings.

286 This subgroup, when compared with the <5 year group, experien

287 d DLBCL trials failed to identify prognostic subgroups, whereas dual expression of MYC and BCL2 was p

288 pertensive heart disease compared with other subgroups, whereas Mexicans experienced higher rates of

289 The subgroup with an IMiD-14 score higher than the cutoff wa

290 enced by exclusion of the favorable clinical subgroup with an initial dFLC <50 mg/L.

291 s of blood eosinophils to identify a patient subgroup with more severe disease, more frequent exacerb

292 A subgroup with optimal CVRFs (n = 740) was also defined a

293 test for interaction of treatment effect in subgroups with and without such a history.

294 tistical methods and persisted among patient subgroups with diabetes, obesity, moderately impaired ej

295 respiratory distress syndrome (ARDS) patient subgroups with differential outcomes from HFOV.

296 This family of proteins contains two subgroups with distinct characteristics.

297 herd immunity disproportionately benefiting subgroups with high vaccination rates.

298 es in ocular features between patients in XP subgroups with impaired transcription coupled nucleotide

299 ferences between the medulloblastoma disease subgroups with significant potential for clinical exploi

300 TDA revealed two large subgroups within the study population based solely on lo